BlossomHill Therapeutics, Inc. (BLSM) Insider Trading
Sector: N/A · Market Cap: $789M · 0 insider purchases in the last 7 days
No open market insider purchases at BlossomHill Therapeutics, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track BLSM on your watchlist.
Start for FreeAbout BlossomHill Therapeutics, Inc. Insider Trading
2 insiders at BlossomHill Therapeutics, Inc. (BLSM) have purchased stock in the past 90 days, totaling $107K across 2 transactions (6,700 shares).
The most recent purchase was by Director Schmid John P. on August 10, 2026 — a $96K buy of 6,000 shares at $16.00, bringing his total holdings to 6,000 shares.
Insiders who purchased: Schmid John P. (Director, 1 buy totaling $96K); Keyes Jason A (CFO, 1 buy totaling $11K).
This insider buying is notable given that BLSM had no recorded open market purchases in the nine months before that.
BLSM is in the N/A sector within the N/A industry with a market cap of $789M.
Track BLSM insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.
More Insider Trading in N/A
MEXICO FUND INC
82 purchases (7d)
GFNEW GERMANY FUND INC
91 purchases (7d)
FTHYFIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND
3 purchases (7d)
GAMGENERAL AMERICAN INVESTORS CO INC
46 purchases (7d)
ARDCAres Dynamic Credit Allocation Fund, Inc.
2 purchases (7d)
FINSAngel Oak Financial Strategies Income Term Trust
15 purchases (7d)